Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lifestyle behaviors during exam periods and their association with academic performance among Palestinian medical students: a cross-sectional study.

BMC medical education·2026
Same author

Diabetes distress: What a clinician needs to know - A South Asian perspective.

Best practice & research. Clinical endocrinology & metabolism·2026
Same author

Erector spinae plane block (ESPB) versus modified pectoral plane block (PECS II) in managing post modified radical mastectomy pain: A systematic review and meta-analysis.

Surgical oncology·2026
Same author

Pure Alpha Versus Mixed Adrenergic Vasopressors Perioperative Outcomes in Autologous Free Flap Surgery: A Systematic Review and Meta-Analysis.

Plastic surgery (Oakville, Ont.)·2026
Same author

Longitudinal effects of technostress on bedtime procrastination and sleep quality among university students.

Scientific reports·2026
Same author

Nanogenomic synergy in Diabetes care: precision therapeutics for patients with multiple long-term conditions.

Frontiers in endocrinology·2026

Related Experiment Video

Updated: May 20, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Diabetic emergencies including hypoglycemia during Ramadan.

Jamal Ahmad1, Md Faruque Pathan, Mohammed Abdul Jaleel

  • 1Rajiv Gandhi Centre for Diabetes and Endocrinology, J. N. Medical College, Aligarh Muslim University, Aligarh, India.

Indian Journal of Endocrinology and Metabolism
|July 28, 2012
PubMed
Summary

Physicians find Ramadan fasting acceptable for well-managed type 2 diabetes patients. However, careful blood glucose monitoring is crucial to prevent hypoglycemia and hyperglycemia during fasting periods.

Keywords:
Diabetic ketoacidosisfastinghyperglycemiahypoglycemiainfectionketosis

More Related Videos

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Experiment Videos

Last Updated: May 20, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Islamic Medicine

Background:

  • Ramadan fasting presents unique challenges for individuals with diabetes.
  • Physician consensus suggests fasting is permissible for select type 2 diabetes patients.
  • Potential risks include hypoglycemia and hyperglycemia during fasting.

Purpose of the Study:

  • To outline management strategies for diabetic patients observing Ramadan fasts.
  • To provide guidance on preventing and managing diabetic emergencies during Ramadan.
  • To inform healthcare providers on best practices for diabetes care during Ramadan.

Main Methods:

  • Review of existing literature and clinical guidelines on diabetes management during Ramadan.
  • Consensus-based recommendations from healthcare professionals.
  • Discussion of pharmacological and non-pharmacological interventions.

Main Results:

  • Type 2 diabetes patients require strict adherence to diet, medication, and glucose monitoring.
  • Type 1 diabetes patients may benefit from fast-acting insulin and comprehensive diabetes education.
  • Management strategies focus on regular blood glucose monitoring to mitigate risks.

Conclusions:

  • Careful patient selection and education are vital for safe Ramadan fasting in diabetic individuals.
  • Proactive management and monitoring can minimize complications associated with fasting.
  • This consensus statement provides a framework for managing diabetic emergencies during Ramadan.